Premium
Bromocriptine and Parkinson's disease: A 16‐hour clinical evaluation
Author(s) -
Grøn Ulla,
Friis Mogens Laue,
Pakkenberg Henning
Publication year - 1980
Publication title -
acta neurologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.967
H-Index - 95
eISSN - 1600-0404
pISSN - 0001-6314
DOI - 10.1111/j.1600-0404.1980.tb01475.x
Subject(s) - bromocriptine , hyperkinesia , medicine , rating scale , ingestion , psychology , developmental psychology , hormone , prolactin
The disability score (Webster rating scale) in 12 parkinsonian patients on bromocriptine treatment was evaluated hourly from 06–22 h. Bromocriptine was taken at fixed hours (06, 14, and 22 h) in equal doses. No systematic changes during the day related to bromocriptine ingestion were observed. Only one patient experienced pronounced hyperkinesia. “On‐off” phenomenas were not observed during the treatment with bromocriptine.